GENERIC NAME OF THE MEDICINAL PRODUCT:

A. Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg)
B. Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg)
Each film coated bilayered tablet contains:
Telmisartan IP………………………………………40mg
Cilnidipine IP…………………………………………10mg
Metoprolol succinate IP (47.5mg)
Equivalent to Metoprolol tartrate………..50mg
( as extended release)
Colour: Sunset Yellow Lake


B) Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+25mg)
Each film coated bilayered tablet contains:
Telmisartan IP………………………………………40mg
Cilnidipine IP…………………………………………10mg
Metoprolol succinate IP (23.75mg)
Equivalent to Metoprolol tartrate………..25mg
( as extended release)
Colour: Ponceau-4R Lake and Titanium Dioxide IP

THERAPEUTIC INDICATIONS:

Telmisartan + Cilnidipine + Metoprolol Succinate belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke.

CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

Moisture sensitive tablets- do not remove from strip until immediately before administration.

WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.

SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.
Dosage: As directed by the Physician.

Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg) Technical Specification:

Product Name: Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets
Brand Name: Generic
Strength:  (40mg+10mg+50mg), (40mg+10mg+25mg)
Dosage Form: Tablets (Film coated)
Route of Administration: Via Oral Route
Packing: 10 Blister strips of 10 Tablets Each
Pack Insert/Leaflet: PIL (Patient Information Leaflet)
Regulatory Documents: COA, MOA, Stability Studies, GMP
Therapeutic use: Antihypertensive
Indication: Telmisartan + Cilnidipine + Metoprolol Succinate belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke.
Storage: Store at temperature not exceeding 30℃.  Store in cool, dry & dark place. Protect from Light & moisture.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg)

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg)
    Each film coated bilayered tablet contains:
    Telmisartan IP………………………………………40mg
    Cilnidipine IP…………………………………………10mg
    Metoprolol succinate IP                          (47.5mg)
    Equivalent to Metoprolol tartrate………..50mg
    ( as extended release)
    Colour: Sunset Yellow Lake

THERAPEUTIC INDICATIONS:

Telmisartan + Cilnidipine + Metoprolol Succinate belongs to the group of anti-hypertensive medicines used to treat high blood pressure (hypertension). CILNIDIPINE+METOPROLOL SUCCINATE+TELMISARTAN helps lower the blood pressure, thereby reducing the chances of heart problems such as heart attack and stroke.CAUTION & SCHEDULE:

CAUTION: Read enclosed leaflet before use.
Keep medicine out of reach of children.
Tablet to be swallowed as a whole, and not to be chewed or crushed.

Moisture sensitive tablets– do not remove from strip until immediately before administration.

WARNING: WHEN PREGNANCY IS DETECTED, TELMISARTAN SHOULD BE DISCONTINUED AS SOON AS POSSIBLE AS IT CAN CAUSE INJURY AND EVEN DEATH TO THE DEVELOPING FETUS WHEN USED DURING SECOND AND THIRD TRIMESTERS OF PREGNANCY.

SCHEDULE: SCHEDULE H PRESCRIPTION DRUG CAUTION: Not to be sold by retail without the prescription of a Registered Medical Practitioner.

STORAGE & DOSAGE:

Storage: Store at temperature not exceeding 30℃.
Store in cool, dry & dark place.
Protect from Light & moisture.

Dosage: As directed by the Physician.

Introduction to Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg)

Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg) are a potent fixed-dose combination (FDC) designed specifically for the management of hypertension (high blood pressure). This combination therapy effectively lowers blood pressure levels, reducing the risk of stroke, heart attack, and other cardiovascular complications. Due to the rising prevalence of hypertension worldwide, especially in developing regions, the demand for high-quality antihypertensive medications has surged.

What Are These Tablets?

This combination includes three active ingredients:

  • Telmisartan (40mg): An angiotensin II receptor blocker that relaxes blood vessels, easing blood flow and reducing blood pressure.
  • Cilnidipine (10mg): A calcium channel blocker that dilates blood vessels and enhances blood flow.
  • Metoprolol Succinate (ER) (50mg): An extended-release beta-blocker that decreases heart rate and cardiac output, further aiding in blood pressure control.

This unique combination provides a synergistic effect, making it especially effective for resistant hypertension or patients requiring multi-drug therapy.

Global Market and Demand

The global burden of hypertension is increasing, with significant prevalence in Asia, Africa, and Latin America. India, being a major pharmaceutical manufacturing hub, supplies Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets to over 50 countries. The combination’s efficacy, affordability, and compliance advantages make it highly sought after by healthcare providers worldwide.

Why Is This Combination Popular?

  • Enhanced efficacy in blood pressure reduction
  • Prevention of stroke and heart attack
  • Suitable for resistant hypertension
  • Once-daily dosing for improved patient adherence

The combination’s versatility and proven results have driven worldwide demand, creating opportunities for importers and exporters to expand their portfolio.


Why Taj Pharma Is the Most Trusted Manufacturer & Exporter in India

1. State-of-the-Art Manufacturing Facilities

Taj Pharma’s manufacturing units in Vapi, Gujarat, and Mumbai, Maharashtra, are equipped with cutting-edge technology and adhere strictly to WHO-GMP standards. Their facilities ensure high-quality production of Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets that meet international quality benchmarks.

2. Competitive Pricing & Stringent Quality Control

Taj Pharma offers affordable prices without compromising on quality. Their rigorous quality control processes, including stability testing and batch validation, guarantee the consistency and safety of every batch.

3. Comprehensive Regulatory & Export Support

The company provides extensive regulatory documentation, such as Certificates of Analysis (COA), GMP certificates, and export licenses. They also prepare CTD dossiers suitable for global registration, streamlining the approval process.

4. Extensive Global Reach & Robust Supply Chain

Taj Pharma exports to over 20 countries, including North America, Europe, Africa, and Southeast Asia. Their efficient logistics and customs clearance support ensure timely delivery, fostering long-term partnerships.

5. Industry Reputation & Customer Satisfaction

Recognized as a top manufacturer, exporter, and supplier in India, Taj Pharma has built a reputation for delivering quality medicines consistently. Their focus on transparency, compliance, and customer satisfaction makes them the preferred choice for global clients.


In-Depth Details for Importers, Exporters & Buyers

Regulatory Documentation and Certifications

Taj Pharma provides all necessary regulatory documents for seamless international registration, including WHO-GMP, EU-GMP, COPP, and CTD dossiers. These certifications enable quick approvals and market entry in target countries.

Custom Packaging & Labeling

Custom packaging options are available to meet regional regulatory standards. Labels can be translated into local languages, and packaging formats include bottles, blisters, and cartons designed to ensure product stability during transit.

Shelf-life, Storage, and Dosage

  • Shelf-life: 2-3 years, depending on storage conditions
  • Storage Conditions: Store in a cool, dry place, protected from light and moisture
  • Dosage: Take one tablet daily at the same time, preferably with water, as prescribed

Target Countries & Export Markets

Taj Pharma’s export markets include the United States, European Union countries, Middle East, Africa, Southeast Asia, and Latin America. Their compliance with international standards ensures smooth regulatory processes.


 The Most Trusted Manufacturer & Exporter

1. Cutting-Edge Manufacturing Infrastructure

Taj Pharma’s facilities incorporate the latest technology and equipment, ensuring batch-to-batch consistency and high safety standards.

2. Competitive Pricing & Quality Assurance

They offer cost-effective pricing without compromising on quality—ideal for bulk buyers and international markets.

3. Strong Global Supply Chain

Their extensive logistics network guarantees timely delivery across continents, supported by proper documentation and customs facilitation.

4. Certifications & Regulatory Compliance

Products are certified with WHO-GMP, EU-GMP, and ISO standards, simplifying registration and compliance in various markets.


Technical Product Specification Table

Parameter Specification
Active Ingredients Telmisartan 40mg, Cilnidipine 10mg, Metoprolol Succinate 50mg
Dosage Form Extended-release tablets
Appearance White, round, film-coated tablets
Shelf Life 2-3 years
Storage Conditions Store in a cool, dry place, protected from light
Certifications WHO-GMP, EU-GMP, COPP, ISO

Call to Action:

Are you seeking a reliable manufacturer and supplier of Telmisartan + Cilnidipine + Metoprolol Succinate (ER) Tablets (40mg+10mg+50mg) in India? Taj Pharma’s quality products, competitive prices, and international certifications make us your ideal partner. Contact us today for bulk orders, distributor opportunities, or export collaborations.

Email: info@tajpharma.com
Phone: +9122-2634 1274
Website: www.tajpharma.com


Top 10 FAQs

1. What conditions do these tablets treat?

They are used to effectively manage hypertension, reducing the risk of stroke and heart attacks.

2. How should I take these tablets?

Take one tablet daily at the same time, with or without food, as per your doctor’s instructions.

3. What are common side effects?

Possible side effects include dizziness, headache, nausea, ankle swelling, flushing, and increased potassium levels. Most side effects are mild and transient.

4. Can I stop taking these suddenly?

No, always consult your doctor before discontinuing medication to prevent rebound hypertension.

5. Are there any precautions?

Inform your healthcare provider of all medical conditions and medications to avoid adverse interactions.

6. Can I consume alcohol with these tablets?

It’s best to avoid alcohol, as it may intensify side effects like dizziness and low blood pressure.

7. How long before I see blood pressure reduction?

Blood pressure may decrease within hours, but full effects can take a few days to weeks.

8. Is it safe for pregnant women?

Consult your doctor; these medications should only be used during pregnancy if prescribed.

9. How should I store these tablets?

Store in a cool, dry place, away from sunlight and children.

10. What if I miss a dose?

Take it as soon as you remember. If it’s near the next dose, skip the missed dose and continue your regular schedule.